Cocrystal Pharma Stock Probability of Future Stock Price Finishing Under 2.72

COCP Stock  USD 1.86  0.02  1.06%   
Cocrystal Pharma's future price is the expected price of Cocrystal Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cocrystal Pharma performance during a given time horizon utilizing its historical volatility. Check out Cocrystal Pharma Backtesting, Cocrystal Pharma Valuation, Cocrystal Pharma Correlation, Cocrystal Pharma Hype Analysis, Cocrystal Pharma Volatility, Cocrystal Pharma History as well as Cocrystal Pharma Performance.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.
  
As of 12/12/2024, Price To Sales Ratio is likely to drop to 382.56. In addition to that, Price Earnings Ratio is likely to drop to -0.97. Please specify Cocrystal Pharma's target price for which you would like Cocrystal Pharma odds to be computed.

Cocrystal Pharma Target Price Odds to finish below 2.72

The tendency of Cocrystal Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 2.72  after 90 days
 1.86 90 days 2.72 
close to 99
Based on a normal probability distribution, the odds of Cocrystal Pharma to stay under $ 2.72  after 90 days from now is close to 99 (This Cocrystal Pharma probability density function shows the probability of Cocrystal Stock to fall within a particular range of prices over 90 days) . Probability of Cocrystal Pharma price to stay between its current price of $ 1.86  and $ 2.72  at the end of the 90-day period is about 54.97 .
Given the investment horizon of 90 days Cocrystal Pharma has a beta of 0.27 suggesting as returns on the market go up, Cocrystal Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cocrystal Pharma will be expected to be much smaller as well. Additionally Cocrystal Pharma has an alpha of 0.2133, implying that it can generate a 0.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Cocrystal Pharma Price Density   
       Price  

Predictive Modules for Cocrystal Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cocrystal Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cocrystal Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.091.856.78
Details
Intrinsic
Valuation
LowRealHigh
0.193.758.68
Details
2 Analysts
Consensus
LowTargetHigh
8.809.6710.73
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.51-0.49-0.47
Details

Cocrystal Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cocrystal Pharma is not an exception. The market had few large corrections towards the Cocrystal Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cocrystal Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cocrystal Pharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.21
β
Beta against Dow Jones0.27
σ
Overall volatility
0.16
Ir
Information ratio 0.03

Cocrystal Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cocrystal Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cocrystal Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cocrystal Pharma may become a speculative penny stock
Cocrystal Pharma had very high historical volatility over the last 90 days
Cocrystal Pharma has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (17.98 M) with loss before overhead, payroll, taxes, and interest of (8.79 M).
Cocrystal Pharma currently holds about 51.03 M in cash with (14.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Cocrystal Pharma has a frail financial position based on the latest SEC disclosures
Roughly 32.0% of the company shares are held by company insiders
Latest headline from news.google.com: Cocrystal Pharma Price-to-Operating-Cash-Flow - GuruFocus.com

Cocrystal Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cocrystal Stock often depends not only on the future outlook of the current and potential Cocrystal Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cocrystal Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding9.7 M
Cash And Short Term Investments26.4 M

Cocrystal Pharma Technical Analysis

Cocrystal Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Cocrystal Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cocrystal Pharma. In general, you should focus on analyzing Cocrystal Stock price patterns and their correlations with different microeconomic environments and drivers.

Cocrystal Pharma Predictive Forecast Models

Cocrystal Pharma's time-series forecasting models is one of many Cocrystal Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cocrystal Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Cocrystal Pharma

Checking the ongoing alerts about Cocrystal Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cocrystal Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cocrystal Pharma may become a speculative penny stock
Cocrystal Pharma had very high historical volatility over the last 90 days
Cocrystal Pharma has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (17.98 M) with loss before overhead, payroll, taxes, and interest of (8.79 M).
Cocrystal Pharma currently holds about 51.03 M in cash with (14.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Cocrystal Pharma has a frail financial position based on the latest SEC disclosures
Roughly 32.0% of the company shares are held by company insiders
Latest headline from news.google.com: Cocrystal Pharma Price-to-Operating-Cash-Flow - GuruFocus.com

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.